ArticleEuropean journal of medicinal chemistry2022

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals.

Yugendar R Alugubelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.